Is Clonixine [INN-French] Safe in Breastfeeding
Question
I am a breastfeeding mother and i want to know if it is safe to use Clonixine [INN-French]? Is Clonixine [INN-French] safe for nursing mother and child? Does Clonixine [INN-French] extracts into breast milk? Does Clonixine [INN-French] has any long term or short term side effects on infants? Can Clonixine [INN-French] influence milk supply or can Clonixine [INN-French] decrease milk supply in lactating mothers?
Clonixine [INN-French] lactation summary
![Clonixine [INN-French] usage has low risk in breastfeeding](/images/breastfeeding/low-risk-in-breastfeeding.jpg "Clonixine [INN-French] breastfeeding")
- DrLact safety Score for Clonixine [INN-French] is 3 out of 8 which is considered Low Risk as per our analyses.
- A safety Score of 3 indicates that usage of Clonixine [INN-French] may cause some minor side effects in breastfed baby.
- Our study of different scientific research indicates that Clonixine [INN-French] may cause moderate to no side effects in lactating mother.
- Most of scientific studies and research papers declaring usage of Clonixine [INN-French] low risk in breastfeeding are based on normal dosage and may not hold true for higher dosage.
- While using Clonixine [INN-French] We suggest monitoring child for possible reactions. It is also important to understand that side effects vary largely based on age of breastfed child and time of medication in addition to dosage.
- Score calculated using the DrLact safety Version 1.2 model, this score ranges from 0 to 8 and measures overall safety of drug in lactation. Scores are primarily calculated using publicly available case studies, research papers, other scientific journals and publically available data.
Answer by Dr. Ru: About Clonixine [INN-French] usage in lactation
A fecha de última actualización no encontramos datos publicados sobre su excreción en leche materna. Sus datos farmacocinéticos (elevado porcentaje de fijación a proteínas y corta vida media) hacen poco probable el paso a leche de cantidades significativas. Hasta conocer más datos publicados sobre este fármaco en relación con la lactancia, pueden ser preferibles alternativas conocidas más seguras, especialmente durante el periodo neonatal y en caso de prematuridad.
Alternate Drugs for Antiinflammatory and antirheumatic products, non-steroids and others specific. ATC M01A-C
Auranofin(Low Risk)
Celecoxib(Safe)
Diclofenac(Safe)
Etodolac(Low Risk)
Fenoprofen(Safe)
Flurbiprofen(Safe)
Ibuprofen(Safe)
Indomethacin(Safe)
Ketorolac(Safe)
Meclofenamate(Low Risk)
Mefenamic Acid(Safe)
Meloxicam(Low Risk)
Nabumetone(Low Risk)
Naproxen(Low Risk)
Penicillamine(Low Risk)
Piroxicam(Safe)
Sulindac(Low Risk)
Tolmetin(Safe)
Oxaprozin(Low Risk)
Ketoprofen(Safe)
Glucosamine(Safe)
Apazone(Safe)
Niflumic Acid(Low Risk)
Nimesulide(Unsafe)
Parecoxib(Low Risk)
Proglumetacin(Unsafe)
Rofecoxib(Unsafe)
Azapropazone(Safe)
Aceclofenac(Safe)
Aurothiomalate Sodium(Low Risk)
Clonixin(Low Risk)
Dexibuprofen(Safe)
Dexketoprofen(Safe)
Diacerein(Low Risk)
Etoricoxib(Low Risk)
Phenylbutazone(Safe)
Lornoxicam(Low Risk)
Loxoprofen(Low Risk)
Meclofenamic Acid(Low Risk)
Diclofenac Potassium(Safe)
Diclofenac Sodium(Safe)
Chitosamine(Safe)
Azapropazon(Safe)
Ibuprofen Lysine(Safe)
Etodolic Acid(Low Risk)
Indometacin(Safe)
Indomethacin Sodium(Safe)
Butadione(Safe)